Muscle inflammation susceptibility: A prognostic index of recovery potential after hip arthroplasty?

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 8, 2015, Pages E670-E679

  Bamman, Marcas M ^a,f,g   Ferrando, Arny A ^b   Evans, Richard P ^c   Stec, Michael J ^a,f   Kelly, Neil A ^a,f   Gruenwald, Johannes M ^d   Corrick, Katie L ^a   Trump, Jesse R ^a   Singh, Jasvinder A ^e,f,g,h  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BIRMINGHAM VA MEDICAL CENTER   (United States)

^h Mayo Clinic College of Medicine   (United States)

Author keywords

Inflammation; Muscle atrophy; Muscle protein metabolism; Muscle regeneration; Total hip arthroplasty

Indexed keywords

MUSCLE PROTEIN; RECEPTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS RECEPTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HIP FRACTURE; HIP OSTEOARTHRITIS; HUMAN; HYPERMETABOLISM; MALE; MUSCLE INFLAMMATION SUSCEPTIBILITY; MUSCLE MASS; MYOSITIS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TOTAL HIP PROSTHESIS; ADVERSE EFFECTS; BLOOD; EARLY DIAGNOSIS; GENETICS; HIP ARTHROPLASTY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; OSTEOARTHRITIS, HIP; OUTPATIENT DEPARTMENT; PATHOLOGY; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROGNOSIS; QUADRICEPS FEMORIS MUSCLE; REOPERATION; UNITED STATES; UNIVERSITY HOSPITAL;

ARKANSAS; ARTHROPLASTY, REPLACEMENT, HIP; BIOMARKERS; BIOPSY, NEEDLE; CYTOKINES; DISEASE SUSCEPTIBILITY; EARLY DIAGNOSIS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MYOSITIS; OSTEOARTHRITIS, HIP; OUTPATIENT CLINICS, HOSPITAL; POSTOPERATIVE COMPLICATIONS; PRECISION MEDICINE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUADRICEPS MUSCLE; RECEPTORS, TUMOR NECROSIS FACTOR; REOPERATION;

EID: 84929650155     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00576.2014     Document Type: Article

References (35)

1. Bakkar N, Guttridge DC. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev 90: 495–511, 2010.
2. Bamman MM, Ragan RC, Kim JS, Cross JM, Hill VJ, Tuggle SC, Allman RM. Myogenic protein expression before and after resistance loading in 26- and 64-yr-old men and women. J Appl Physiol 97: 1329–1337, 2004.
3. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. IKKbeta/ NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285–298, 2004.
4. Chazaud B, Brigitte M, Yacoub-Youssef H, Arnold L, Gherardi R, Sonnet C, Lafuste P, Chretien F. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc Sport Sci Rev 37: 18–22, 2009.
5. Chen SE, Jin B, Li YP. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 292: C1660–C1671, 2007.
6. Dechartres A, Boutron I, Nizard R, Poiraudeau S, Roy C, Ravaud JF, Ravaud P. Evolution of disability in adults with hip arthroplasty: a national longitudinal study. Arthritis Rheum 57: 364–371, 2007.
7. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Healthrelated quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 86-A: 963–974, 2004.
8. Ferrando AA, Paddon-Jones D, Hays NP, Kortebein P, Ronsen O, Williams RH, McComb A, Symons TB, Wolfe RR, Evans W. EAA supplementation to increase nitrogen intake improves muscle function during bed rest in the elderly. Clin Nutr 29: 18–23, 2010.
9. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 25: 5826–5839, 2006.
10. Griffiths RD, Hinds CJ, Little RA. Manipulating the metabolic response to injury. Br Med Bull 55: 181–195, 1999.
11. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 98: 911–917, 2005.
12. Healthcare Cost and Utilization Project (HCUP). HCUP Facts and Figures 2009. Section 3: Inpatient Hospital Stays by Procedure. Exhibit 3.1 Most Frequent All-listed Procedures. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
13. Jackman RW, Cornwell EW, Wu CL, Kandarian SC. NF-kappaB signaling pathway and transcriptional regulation in skeletal muscle atrophy. Exp Physiol 98: 19–24, 2013.
14. Jensen C, Aagaard P, Overgaard S. Recovery in mechanical muscle strength following resurfacing vs standard total hip arthroplasty–a randomised clinical trial. Osteoarthritis Cartilage 19: 1108–1116, 2011.
15. Kumar A, Bhatnagar S, Paul PK. TWEAK and TRAF6 regulate skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care 15: 233–239, 2012.
16. Levinger I, Levinger P, Trenerry MK, Feller JA, Bartlett JR, Bergman N, McKenna MJ, Cameron-Smith D. Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum 63: 1343–1348, 2011.
17. Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) 86: 1113–1126, 2008.
18. Lu A, Proto JD, Guo L, Tang Y, Lavasani M, Tilstra JS, Niedernhofer LJ, Wang B, Guttridge DC, Robbins PD, Huard J. NF-kappaB negatively impacts the myogenic potential of muscle-derived stem cells. Mol Ther 20: 661–668, 2012.
19. Mayhew DL, Hornberger TA, Lincoln HC, Bamman MM. Eukaryotic initiation factor 2B epsilon induces cap-dependent translation and skeletal muscle hypertrophy. J Physiol 589: 3023–3037, 2011.
20. Merritt EK, Cross JM, Bamman MM. Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury. J Burn Care Res 33: 291–297, 2012.
21. Merritt EK, Stec MJ, Thalacker-Mercer A, Windham ST, Cross JM, Shelley DP, Craig Tuggle S, Kosek DJ, Kim JS, Bamman MM. Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans. J Appl Physiol (1985) 115: 937–948, 2013.
22. Rasch A, Bystrom AH, Dalen N, Martinez-Carranza N, Berg HE. Persisting muscle atrophy two years after replacement of the hip. J Bone Joint Surg Br 91: 583–588, 2009.
23. Rasch A, Dalen N, Berg HE. Muscle strength, gait, and balance in 20 patients with hip osteoarthritis followed for 2 years after THA. Acta Orthop 81: 183–188, 2010.
24. Reardon K, Galea M, Dennett X, Choong P, Byrne E. Quadriceps muscle wasting persists 5 months after total hip arthroplasty for osteoarthritis of the hip: a pilot study. Intern Med J 31: 7–14, 2001.
25. Relaix F, Zammit PS. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139: 2845–2856, 2012.
26. Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol 28: 1419–1430, 2009.
27. Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord 11: 90, 2010.
28. Singh JA, Lewallen DG. Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplasty. BMC Med 11: 144, 2013.
29. Singh JA, Lewallen DG. Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty. Rheumatology (Oxford) 52: 916–923, 2013.
30. Singh JA, Lewallen DG. Predictors of activity limitation and dependence on walking aids after primary total hip arthroplasty. J Am Geriatr Soc 58: 2387–2393, 2010.
31. Singh JA, Lewallen DG. Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: a cohort study using an institutional joint registry. Arthritis Res Ther 14: R248, 2012.
32. Singh JA, Vessely MB, Harmsen WS, Schleck CD, Melton LJ, 3rd Kurland RL, Berry DJ. A population-based study of trends in the use of total hip and total knee arthroplasty, 1969–2008. Mayo Clin Proc 85: 898–904, 2010.
33. Thalacker-Mercer A, Stec M, Cui X, Cross J, Windham ST, Bamman MM. Cluster analysis reveals differential transcript profiles associated with resistance training-induced human skeletal muscle hypertrophy. Physiol Genomics 45: 499–507, 2013.
34. Zhang XJ, Chinkes DL, Wolfe RR. Measurement of muscle protein fractional synthesis and breakdown rates from a pulse tracer injection. Am J Physiol Endocrinol Metab 283: E753–E764, 2002.
35. Zheng B, Ohkawa S, Li H, Roberts-Wilson TK, Price SR. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/ MAFbx expression during glucocorticoid-induced skeletal muscle atrophy. FASEB J 24: 2660–2669, 2010.